Literature DB >> 8906825

A residue in the center of peptide QL9 affects binding to both Ld and the T cell receptor.

C J Schlueter1, T C Manning, B A Schodin, D M Kranz.   

Abstract

The TCR from the alloreactive clone 2C recognizes p2C (LSPFPFDL)/Ld and QL9 (QLSPFPFDL)/Ld complexes with affinities of 2 x 10(6) and 10(7) M(-1). Recently, it was proposed that the Phe at position 4 of p2C is critical for recognition by the 2C TCR. To further characterize the role of this peptide position in binding to Ld and in recognition by the 2C TCR, we changed the corresponding peptide position in QL9 (position 5) to other amino acids. Binding affinities of these peptides for Ld and of the peptide/Ld complexes for a soluble single chain TCR were determined. Unexpectedly, it was shown that this peptide position has a significant effect on Ld binding (100-fold), with positively charged and hydrophobic residues having a beneficial effect and negatively charged residues having a detrimental effect. Measurements of the binding affinities of these peptide/Ld complexes for the 2C TCR showed that at 4 degrees C only a Tyr substitution at this position retained high affinity for the TCR. However, significant differences in TCR binding were observed among QL9 peptide variants at 4 degrees C compared with that at 37 degrees C. The influence of this peptide position on both Ld binding and TCR binding may suggest that the 2C TCR recognizes an Ld conformational determinant that is altered by interactions with the residue at position 5 of QL9. A strong correlation was also observed between peptide-Ld affinity and the ability of peptides to sensitize Ld target cells for lysis by CTL 2C. The results are considered in view of recent models on the relationship between T cell activity and TCR-peptide-MHC binding properties.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8906825

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  In vitro evolution of a T cell receptor with high affinity for peptide/MHC.

Authors:  P D Holler; P O Holman; E V Shusta; S O'Herrin; K D Wittrup; D M Kranz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  Cellular uptake followed by class I MHC presentation of some exogenous peptides contributes to T cell stimulatory capacity.

Authors:  Susan E Brophy; Lindsay L Jones; Phillip D Holler; David M Kranz
Journal:  Mol Immunol       Date:  2006-12-12       Impact factor: 4.407

3.  The same major histocompatibility complex polymorphism involved in control of HIV influences peptide binding in the mouse H-2Ld system.

Authors:  Samanthi Narayanan; David M Kranz
Journal:  J Biol Chem       Date:  2013-09-24       Impact factor: 5.157

Review 4.  T cell receptor binding kinetics and special role of Valpha in T cell development and activation.

Authors:  N R Gascoigne; S M Alam; C M Lin; M V McGuire; S Marine; N Niederberger; S Redpath; B C Sim; P J Travers; P Yachi; M A Zal; T Zal
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

5.  Opposite effects of endogenous peptide-MHC class I on T cell activity in the presence and absence of CD8.

Authors:  Jennifer D Stone; David H Aggen; Adam S Chervin; Samanthi Narayanan; Thomas M Schmitt; Philip D Greenberg; David M Kranz
Journal:  J Immunol       Date:  2011-03-30       Impact factor: 5.422

6.  Engineering the binding properties of the T cell receptor:peptide:MHC ternary complex that governs T cell activity.

Authors:  Natalie A Bowerman; Terence S Crofts; Lukasz Chlewicki; Priscilla Do; Brian M Baker; K Christopher Garcia; David M Kranz
Journal:  Mol Immunol       Date:  2009-09       Impact factor: 4.407

7.  TCR scanning of peptide/MHC through complementary matching of receptor and ligand molecular flexibility.

Authors:  William F Hawse; Soumya De; Alex I Greenwood; Linda K Nicholson; Jaroslav Zajicek; Evgenii L Kovrigin; David M Kranz; K Christopher Garcia; Brian M Baker
Journal:  J Immunol       Date:  2014-02-12       Impact factor: 5.422

8.  Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8+ T Cell-Effector Responses.

Authors:  Michael E Birnbaum; Stephanie K Dougan; Eleanor Clancy-Thompson; Christine A Devlin; Paul M Tyler; Mariah M Servos; Lestat R Ali; Katherine S Ventre; M Aladdin Bhuiyan; Patrick T Bruck
Journal:  Cancer Immunol Res       Date:  2018-10-23       Impact factor: 11.151

9.  Different strategies adopted by K(b) and L(d) to generate T cell specificity directed against their respective bound peptides.

Authors:  Natalie A Bowerman; Leremy A Colf; K Christopher Garcia; David M Kranz
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

10.  Different thermodynamic binding mechanisms and peptide fine specificities associated with a panel of structurally similar high-affinity T cell receptors.

Authors:  Lindsay L Jones; Leremy A Colf; Alexander J Bankovich; Jennifer D Stone; Yi-Gui Gao; Choi Mui Chan; Raven H Huang; K Christopher Garcia; David M Kranz
Journal:  Biochemistry       Date:  2008-11-25       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.